TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ORKA

Oruka Therapeutics, Inc.

Healthcare · Biotechnology

85.50$ -4.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ORKA
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025
– – – – – – – – – – – – – – – – – – – –
– +19.3% -26.4% -90.6% +107.7% -26.0% +78.1% -92.9% -39.5% -53.8% +58.3% +26.3% +12.5% -18.5% +304.5% +4.5% -2.2% +25.3% -76.3% +207.4%
– – – – – – – – – – – – – – – – – – – –
– +440.9% -190.3% – -9,478.6% – – – – -133.0% – +284.6% -78.8% -815.3% – +325.6% -101.5% – – -122.0%
– -5.0% -84.4% +252.8% -86.2% -97.8% +375.1% -100.0% – -40.6% -42.1% +9.1% -75.0% +33.3% +0.0% +375.0% +126.3% -95.3% +9,350.0% +10.6%
– +5,182.0% – -112.0% – -99.4% +657.0% – – -40.6% -42.1% +149,118.2% – -76.4% -100.1% +375.0% +126.3% -95.3% +16,506,250.0% -70.7%
– – – – – – – – – – – – – – – – – – – –
– +49.9% -102.8% – -130.3% – -47.1% -72.7% +1,715.7% -58.1% +323.7% – – -46.9% +111.3% +638.6% -52.3% – – -62.1%
– -40.2% -225.3% – – -3,308.7% – – – -110.1% – -233.9% – -261.0% – +2,219.5% -89.5% -354.5% – -160.6%
– – – – – – – – – – – – – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?